ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "juvenile idiopathic arthritis (JIA) and meta-analysis"

  • Abstract Number: 2165 • ACR/ARHP Annual Meeting 2013

    Efficacy and Safety Of Biologic Agents In Patients With Poly-Articular Juvenile Idiopathic Arthritis: Network Meta-Analysis Of Randomized Controlled Withdrawal Trials

    Gil Amarilyo1, Simon Tarp2, Ivan Foeldvari3, Neta Cohen4, Tracy D. Pope5, Jennifer M.P. Woo6, Robin Christensen2 and Daniel Furst5, 1Dana-Dwek Children's hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Musculoskeletal Statistics Unit, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, 3Department of Pediatric Rheumatology, Hamburger Zentrum für Kinder und Jugendrheumatologie, Hamburg, Germany, 4Dana-Duek Children's hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 5David Geffen School of Medicine, University of California, Los Angeles, CA, 6Pediatric Rheumatology, Mattel Children's Hospital, University of California, Los Angeles, Los Angeles, CA

    Background/Purpose: Although various biologic agents (BAs) are in use for polyarticular juvenile idiopathic arthritis (pJIA), a combined meta-analytic summary comparing the efficacy and safety among…
  • Abstract Number: 1142 • ACR/ARHP Annual Meeting 2012

    Efficacy of Biologic Agents in Juvenile Idiopathic Arthritis: A Systematic Review Using Indirect Comparisons

    Janneke Anink1, Marieke H. Otten1, Sandra Spronk2 and Lisette W.A. Van Suijlekom-Smit1, 1Pediatric Rheumatology, Erasmus MC Sophia Children's Hospital, Rotterdam, Netherlands, 2Department of Epidemiology and Radiology, Erasmus MC, Rotterdam, Netherlands

    Background/Purpose: During the last decade the availability of biologic agents for the treatment of juvenile idiopathic arthritis (JIA) increased substantially. Because direct head-to-head trials comparing…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology